Search Results

From Pump to Pup: Finding Comfort in 'Baxter'

Izzy, a young cancer fighter and survivor, spent much of her treatment with a special partner by her side: her dog, Baxter. The name ‘Baxter’ has a very special place in Izzy’s health journey – as Baxter manufactures the infusion pump that delivered therapy throughout her cancer treatment.

Meet Izzy, her mom Marilyn, nurse Glenna and, of course, pup Baxter in the video below, which offers a glimpse into Izzy’s brave journey.

Baxter to Present at Jefferies London Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 11:00 a.m. Greenwich Mean Time.      The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, May 19, 2025. 

Baxter to Present at Stifel 2024 Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 8:35 a.m. Eastern Time.      The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, May 17, 2025. 

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock.

Baxter Reports Third-Quarter 2024 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. 

Baxter to Present at UBS Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:15 p.m. Pacific Time.      The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, May 12, 2025. 

Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I320650 to pre-register for the call and receive the call information.

Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community

Baxter International Inc. (NYSE:BAX), a global medtech leader, today shared updates regarding the impact of Hurricane Helene, which brought unprecedented rain and extensive flooding to Western North Carolina, on the operations of its North Cove facility in Marion, N.C. 

Baxter Launches Next Generation of THE VEST for Airway Clearance

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance system, The Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System supports daily therapy for adults and children with certain chronic lung conditions and retained secretions.

Baxter Appoints Jeffrey A. Craig to Its Board

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. Mr. Craig will serve on Baxter’s Audit Committee. His appointment is effective today and brings the total number of directors serving the company to 12.